Back to Agenda
Session 3 : Advancing a paradigm shift in CGT regulatory perspective
Session Chair(s)
So Ra Park
President, Regenerative Medicine Acceleration Foundation, Korea, Republic of
Eui-Kyung Lee, PHD, RPH
Professor, School of Pharmacy, Sungkyunkwan University, Korea, Republic of
Speaker(s)
Maria Vassileva, PHD
Chief Science and Regulatory Officer, DIA, United States
Yasuhiro Kishioka, PHD
Review Director, Office of Cellular and Tissue-based Products, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Jianchao Gao, MD
Associate Researcher, Changping Laboratory, China
Kyeongsoon Kim, PHD
Vice President, Dream CIS, Korea, Republic of
Youngil Koh, MD, PHD
Hemato Oncology, Center for Hematological Oncology, Seoul National University Hospital, Korea, Republic of
Have an account?